Itching to Know: Role of Fibrates in PBC
Authors:
- 1 January 2018
- journal article
- editorial
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 113 (1) , 56-57
Abstract
Approximately one-third of patients with primary biliary cholangitis (PBC) fail to respond to ursodeoxycholic acid (UDCA) and are at risk for progression to biliary cirrhosis and end-stage liver disease. In this paper by Pares et al., the authors evaluate the effect of long-term use of bezafibrate in patients with primary biliary cholangitis (PBC) and inadequate response to UDCA. They found that addition of bezafibrate led to normalization of serum alkaline phosphatase in half of the study subjects and major improvement in pruritus. Here we discuss these findings and place them in context with current knowledge about fibrates in PBC.Keywords
This publication has 10 references indexed in Scilit:
- Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid ResponseAmerican Journal of Gastroenterology, 2018
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitisJournal of Hepatology, 2017
- Long‐term clinical impact and cost‐effectiveness of obeticholic acid for the treatment of primary biliary cholangitisHepatology, 2017
- A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)Journal of Hepatology, 2017
- How the concept of biochemical response influenced the management of primary biliary cholangitis over time.2016
- Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysisClinics and Research in Hepatology and Gastroenterology, 2015
- Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up StudyGastroenterology, 2014
- Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acidAlimentary Pharmacology & Therapeutics, 2010
- Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyDiabetologia, 2010
- Primary biliary cirrhosis # †Hepatology, 2009